| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000021856 |
| Receipt No. | R000025202 |
| Official scientific title of the study | Epidemiological study on the association between obesity and risk for colorectal polyp and cancer |
| Date of disclosure of the study information | 2016/04/10 |
| Last modified on | 2016/04/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Epidemiological study on the association between obesity and risk for colorectal polyp and cancer | |
| Title of the study (Brief title) | Obesity and colorectal cancer/adenoma | |
| Region |
|
|
| Condition | ||
| Condition | Colorectal adenoma and cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the association between obesity and colorectal adenoma/cancer in the Japanese population |
| Basic objectives2 | Others |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The incidence of colorectal adenoma and cancer in individuals with/without obesity |
| Key secondary outcomes | The association between disorder of lipid or glucose metabolism, or insulin resistance and colorectal adenoma/cancer development |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who first underwent colonoscopy | |||
| Key exclusion criteria | (1)Patients with having a past history of colectomy or rectectomy
(2)Patients who have determined by the physicians to have any reasons of unqualified |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroto Miwa |
| Organization | Hyogo College of Medicine |
| Division name | Division of Gasstroenterology, Department of Internal Medicine |
| Address | 1-1, Mukogawa-cho, Nishinomiya |
| TEL | 0798-45-6662 |
| miwahgi@hyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Jiro Watari |
| Organization | Hyogo College of Medicine |
| Division name | Division of Gasstroenterology, Department of Internal Medicine |
| Address | 1-1, Mukogawa-cho, Nishinomiya |
| TEL | 0798-45-6662 |
| Homepage URL | |
| watarij@hyo-med.ac.jp | |
| Sponsor | |
| Institute | Hyogo College of Medicine,
Division of Gasstroenterology, Department of Internal Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Hyogo College of Medicine,
Division of Gasstroenterology, Department of Internal Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | No special instruction |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000025202 |